Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
N/A
-3,073,012 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
N/A
-13,191 Reduced 0.43%
3,073,012 $74.8 Million
Q2 2020

Aug 14, 2020

BUY
N/A
900,547 Added 41.2%
3,086,203 $56.5 Million
Q1 2020

May 15, 2020

BUY
N/A
736,285 Added 50.8%
2,185,656 $28.3 Million
Q4 2019

Feb 14, 2020

SELL
N/A
-59,249 Reduced 3.93%
1,449,371 $18.4 Million
Q3 2019

Dec 10, 2019

BUY
N/A
1,508,620 New
1,508,620 $15.4 Million
Q3 2019

Nov 14, 2019

SELL
N/A
-1,530,449 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
N/A
63,593 Added 4.34%
1,530,449 $13.7 Million
Q1 2019

May 17, 2019

BUY
N/A
1,466,856 New
1,466,856 $14.3 Million

About WuXi Biologics (Cayman) Inc.


  • Ticker 2269.HK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,219,340,032
  • Market Cap $197B
More about 2269.HK
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.